Effectiveness of Wobenzym in Combined Therapy of Chronic Bacterial Prostatitis. Results of Systematic Review and Meta-Analysis
Keywords:
Social integration, responsibilities, relationships and mentorship, Metastasis., resistance, Genomics, sequencing, prosigna, transduction., In Vitro Fertilization, Meta-Analysis, uterine cancer, infertility, ovulation induction, alcohol, dementia, elderly., management, ChatGPT, Acute Pancreatitis, Large Language Model, chronic bacterial prostatitis; Wobenzym; meta-analysis.Abstract
A systematic review and meta-analysis of research data on the effectiveness of the drug Wobenzym in the treatment of chronic bacterial prostatitis was performed. The aim of this study to evaluate the effectiveness of Wobenzym in the complex therapy of chronic bacterial prostatitis. The analysis included randomized and non-randomized controlled studies of the effectiveness of Wobenzim in the complex therapy of chronic bacterial prostatitis. The search was carried out in the databases CENTRAL, PubMed, ICTRP, eLibrary, ClinicalTrials.gov., Google Scholar, CyberLeninka, search engines. The meta-analysis was conducted using the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions. Statistical heterogeneity was assessed using the Cochran test and visually when constructing forest plots. A random effects model and a fixed effect model were used. Works published over the entire period were analyzed, 712 publications were identified, of which 9 fully met the stated criteria, all studies were non-randomized controlled. The final analysis included the results of 1292 patients. Meta-analysis demonstrated the superiority of complex therapy including Wobenzym compared to therapy without Wobenzym in all studied parameters; eradication of the pathogen, decreased quality of life (QoL) scores, an increase in the linear speed of blood flow in the veins and peak systolic blood flow velocity in the arteries of the prostate gland, maximum urine flow rate, reduction in the number of points of the NIH-CPSI “Pain” subscale (difference 5 points) and NIH-CPSI “Quality of Life” subscale. The use of therapy including Wobenzym in patients with chronic prostatitis leads to a greater increase in the number of CDA+, CD8+ lymphocytes, phagocytic activity of lymphocytes, the level of complement CH-100 and immunoglobulins M, G, A. A systematic review/meta-analysis revealed an evident, significant, positive effect of the drug Wobenzym in the complex therapy of patients with chronic bacterial prostatitis, which is associated with its pathogenetic orientation in relation to this group of patients.
References
Suvorov S, Tolstokorov S (2019) Optimization of therapy of patients with chronic ureterogenic prostatitis. ((9)), 10-12.
Vermassen T., Van Praet C., Poelaert F. (2015) Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis. 25((3)), 439-449. https://doi.org/10.11613/BM.2015.045
Kwan A.C.F, Beahm N.P (2020) Fosfomycin for bacterial prostatitis: a review. 56((4)), 106106. https://doi.org/10.1016/j.ijantimicag.2020.106106
Pushkar D.Yu., Rasner P.I., Kotenko D.V. (2018) Specific features of lower urinary tract symptoms in men living in the Moscow Region. Results of the epidemiological study. ((3)), 20-29. https://doi.org/10.18565/urology.2018.3.20-28
Suskind A.M., Berry S.H., Ewing B.A. (2013) The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: Results of the RAND Interstitial cystitis epidemiology male study. 189((1)), 141-145. https://doi.org/10.1016/j.juro.2012.08.088
Panchenko I.A., Brusnev A.B., Garmash O.N. (2019) Men's reproductive service based on the regional specialized center. ((2)), 20-25. https://doi.org/10.29188/2222-8543-2019-11-2-20-24
Shoskes D.A., Nickel J.C., Rackley R.R. (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. 12((2)), 177-183. https://doi.org/10.1038/pcan.2008.42
Filimonov P.N., Kulchavenya E.V. (2019) Consequences of excessive fibrosis formation in patients with chronic prostatitis. 27((2)), 39-41.
Bouilter K., Zayet S. (2022) Efficacy and safety of oral fosfomycin-trometamol in male urinary tract infections with multidrug-resistant enterobacterales. 11((2)), 198. https://doi.org/10.3390/antibioticsl1020198
Shormanov I.S., Solov'ev A.S. (2016) Pathogenic mechanisms of pain in chronic bacterial prostatitis. ((3)), 96-101.
V. Smelov, T. Perekalina, N. Artemenko (2005) Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome. 37(2-3), 61-64. https://doi.org/10.1111/j.1439-0272.2005.00654.x
F.M.E. Wagenlehner, K.G. Naber (2003) Prostatitis: the role of antibiotic treatment. 21(2), 105-108. https://doi.org/10.1007/s00345-003-0333-4
M. Hu, J. Wazir, R. Ullah (2019) Phytotherapy and physical therapy in the management of chronic prostatitis-chronic pelvic pain syndrome. 51(7), 1081-1088. https://doi.org/10.1007/s11255-019-02161-x
N. I Dosta, N. S. Sevostianov (2013) Efficiency of application of enzymo-therapy in complex treatment of a chronic bacterial prostatitis. ((12)), 72-76.
Yu.l. Sternin, B.B. Tetz, G.Yu. Knorring (2010) Modern possibilities of optimization of antibacterial therapy. ((3)), 17-20.
I.B. Mikhailov, Yu.l. Sternin (2012) Selected issues of clinical pharmacology of systemic enzymotherapy. ((1)), 15-19. https://doi.org/10.1002/9780470712184
J. Higgins, J. Thomas Cochrane handbook for systematic reviews of interventions. https://training.cochrane.org/handbook/current
J.P.T. Higgins, S. Green (2008) Cochrane handbook for systematic reviews of interventions: Cochrane book series. 649. https://doi.org/10.1002/9780470712184
O.Yu. Rebrova, V. K. Fedyaeva, G.R. Khachatryan (2015) Adaptation and validation of the cochrane questionnaire to assess risks of bias in randomized controlled trials. ((1)), 9-17.
H.N. Dzhalilov, K.M. Arbuliev, D.N. Dzhalilova, N.M. Gusniev (2020) Improving medical and social rehabilitation of elderly and older patients with chronic bacterial prostatitis. (2), 115-120. https://doi.org/10.25694/URMJ.2020.02.28
E.V. Ershov (2007) Evaluation of prostate blood circulation in patients with chronic prostatitis. 11(1), 103-107.
T.R. Kodiri, L. Saydulloev, K.U. Sayfutloev (2013) Efficacy of Woben-zyme in treatment of chronic prostatitis. (2), 160-161.
N.Yu. Noskov (2004) Use of Wobenzym in complex therapy of patients with chronic prostatitis. 8(3), 84-86. https://doi.org/10.24884/1561-6274-2004-8-3-84-86
V.N. Tkachuk, A.S. Al-Shukri, I.N. Tkachuk, Y.l. Sternin (2015) The results of a 10-year study of efficacy of proteolytic enzymes in patients with chronic prostatitis. 5(2), 5-9. https://doi.org/10.17816/uroved525-9
V.N. Tkachuk, A.E. Lukyanov, N.Y. Noskov (2007) Place of systemic enzymotherapy in complex treatment of patients with chronic prostatitis. (5), 36-41.
D.N. Solihov (2009) Wobenzym in treatment of chronic bacterial prostatitis. 52(5), 400-402.
Kh.N. Dzhalilov, K.M. Arbuliev, M.S. Saidov (2019) To the question of the use of drugs with a polymodal effect in the complex treatment of elderly and senile patients with recurrent chronic bacterial prostatitis. (15), 15JI-160. https://doi.org/10.25694/URMJ.2019.15.32
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
